Kestra Private Wealth Services, LLC Orchard Therapeutics PLC Transaction History

Kestra Private Wealth Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 26, 2022	SELL	$0.7 - $1.51 $7,023 - $15,149	-10,033 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$1.16 - $2.23 $11,638 - $22,373	10,033 New	10,033 $13,000
Q3 2021 Oct 21, 2021	SELL	$2.24 - $4.29 $34,395 - $65,872	-15,355 Closed	0 $0
Q2 2021 Jul 30, 2021	SELL	$4.39 - $7.23 $3,213 - $5,292	-732 Reduced 4.55%	15,355 $67,000
Q1 2021 May 11, 2021	BUY	$4.39 - $9.08 $70,621 - $146,069	16,087 New	16,087 $116,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.